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PEMUTARAN-ELEKTRO DAN PENYEMBURAN-ELEKTRO: 
PENGHASILAN GENTIAN-NANO DAN ZARAH-MIKRO UNTUK 
APLIKASI NUTRASEUTIK / FARMASEUTIK 
  
ABSTRAK 
 
Kajian ini menyiasat teknologi pemutaran-elektro dan penyemburan-elektro dalam 
pengeluaran dan aplikasi struktur nano dan mikro. Satu unit pemutaran-elektro mudah 
telah dibina untuk pemutaran-elektro dan satu unit yang sama telah disesuaikan 
dengan komponen tambahan untuk menampung keperluan yang berbeza untuk 
pemutaran-elektro. Persediaan unit pemutaran-elektro kemudiannya digunakan dalam 
pengeluaran gentian-nano daripada sisa agro, iaitu batang kelapa sawit (OPT), pelepah 
kelapa sawit (OPF) dan okara (sisa pepejal kacang soya) sebagai pembawa bakteria 
probiotik L. acidophilus. Serat terlarut dan hemiselulosa diperolehi daripada rawatan 
alkali sisa agro ditambah dengan polyvinil alkohol 8 % (w/v) dan diputar menjadi 
gentian nano yang seragam saiznya. Sel bacteria L. acidophilus dicampurkan ke dalam 
larutan itu dan diputar menjadi gentian-nano yang mengandungi bakteria probiotik. 
Bakteria masih hidup walaupun dikenakan tegasan ricih dan voltan tinggi semasa 
pemutaran-elektro dan mengekalkan daya maju semasa penyimpanan dalam suhu peti 
sejuk (4 ° C). Selepas penyimpanan selama 21 hari pada suhu sejuk (4 º C), L. 
acidophilus terkandung dalam gentian-nano OPF mengekalkan sehingga 71.9 ± 1.0% 
sel-sel berdaya maju berbanding dengan sampel segar. Teknologi penyemburan-
elektro digunakan untuk menyediakan formulasi ubiquinone (CoQ10), drug BCS 
Kelas II (kelarutan yang rendah, kebolehtelapan yang tinggi) untuk meningkatkan sifat 
keterlarutan dan biokeperolehan oral. Copovidone VA64 dicampur dengan CoQ10 
xx 
 
(1:5, 1:08 dan 1:10 CoQ10:VA64) untuk menghasilkan zarah-mikro.  Zarah-mikro 
amorf yang licin permukaannya dan bersaiz dalam lingkungan 3 hingga 5 μm, 
menunjukkan keterlarutan air yang lebih tinggi berbanding dengan bahan mentah 
CoQ10. Ini dikaitkan dengan perubahan dalam keadaan hablur CoQ10. Penilaian in 
vitro zarah-mikro menunjukkan sifat-sifat meningkatkan biokeperolehan seperti 
pengurangan penghabluran, pengurangan saiz zarah, dan peningkatan keterlarutan 
dalam air. Hal ini dibuktikan lagi dengan kajian in vivo menggunakan model tikus. 
Profil penyerapan jelas menunjukkan bahawa formulasi zarah-mikro mencapai tahap 
plasma tertinggi diikuti oleh campuran fizikal, manakala bahan mentah menunjukkan 
tahap plasma purata CoQ10 yang paling rendah. Tahap penyerapan zarah-mikro 
adalah kira-kira 2.9 kali lebih tinggi daripada bahan mentah CoQ10, dan kira-kira 1.6 
kali lebih tinggi daripada formulasi campuran fizikal. Berdasarkan keputusan kajian 
ini, pemutaran-elektro dan penyemburan-elektro merupakan teknologi berpotensi 
tinggi untuk menghasilkan struktur-nano dan -mikro sebagai mod penghantaran untuk 
bahan bioaktif seperti bakteria probiotik dan ubat-ubatan dengan biokeperolehan oral 
yang rendah. Kemantapan dan fleksibiliti teknologi boleh dioptimumkan untuk 
menghasilkan struktur-nano dengan pelbagai ciri, sesuai untuk fungsi-fungsi spesifik. 
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ELECTROSPINNING AND ELECTROSPRAYING: PRODUCTION OF 
NANOFIBERS AND MICROPARTICLES FOR 
NUTRACEUTICAL / PHARMACEUTICAL APPLICATIONS 
 
ABSTRACT 
 
The present study investigated the technology of electrospinning and electrospraying 
in the production and application of nano- and micro-structures. A simple bench-top 
setup was constructed for electrospinning and a similar unit was adapted with 
additional components to accommodate the different requirement of electrospraying. 
The electrospinning setup was subsequently used in the production of functional 
nanofibers from agricultural waste materials, namely oil palm trunk (OPT), oil palm 
frond (OPF) and okara (solid soy waste) as encapsulants for probiotic bacteria L. 
acidophilus. Solubilised soluble fibers and hemicelluloses obtained from alkaline 
treatment of the agrowaste was added with polyvinyl alcohol 8 % (w/v) and 
successfully electrospun into uniform-sized nanofibers. L. acidophilus was added into 
the solution and electrospun into nanofiber encapsulated probiotic bacteria. The 
bacteria survived the electrospinning conditions of high shear stress and high voltage 
and remained viable during storage at refrigeration temperature (4 °C). OPF nanofiber-
encapsulated L. acidophilus stored at refrigerated temperature (4 ºC), retained up to 
71.9 ± 1.0 % of viable cells compared to fresh samples after 21 day storage. The 
electrospraying technology was applied to prepare ubiquinone (CoQ10), a BCS Class 
II drug (low solubility and high permeability) to enhance its dissolution properties and 
oral bioavailability. Copovidone VA64 was formulated with CoQ10 in various ratios 
(1:5, 1:8 and 1:10 of CoQ10:VA64) to form polymeric microparticles. The smooth 
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amorphous microparticles in the range of 3 to 5 µm, showed enhanced water solubility, 
which could be attributed to the change in crystalline state of CoQ10. In vitro 
evaluation of the electrosprayed microparticles showed bioavailability enhancing 
properties such as reduced crystallinity, reduced particle size, and increased water 
solubility. This was further affirmed in in vivo study using rat model. The absorption 
profiles clearly show that the electrosprayed microparticle preparation achieved the 
highest plasma levels followed by the physical mixture, while the raw material 
produced the lowest mean plasma levels of CoQ10. The extent of absorption of the 
microparticles was approximately 2.9 times higher than that of the raw material 
CoQ10, and approximately 1.6 times over that of the physical mixture formulation. 
On the basis of the findings in this study, electrospinning and electrospraying are 
highly prospective technologies to produce functional nano- and micro-structures as 
delivery vehicles for bioactives such as probiotic bacteria and drugs with poor oral 
bioavailability. The robustness and flexibility of the technology can be optimised to 
produce functional nanostructures with a wide range of properties, suited for specific 
functions. 
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CHAPTER 1: INTRODUCTION 
 
1.1  MICRO-NANO-TECHNOLOGY  
1.1.1 INTRODUCTION  
Micro-technology refers to the fabrication and application of materials in the 
dimensions of 1 to 1000 μm, irrespective of the precise interior or exterior structure. 
In micro-technology and micro-engineering, the most widely researched application 
would be microparticles. Microparticles, encompass two structural subtypes, namely 
“microspheres” which are spherical microparticles and “microcapsules” which are 
microparticles with a distinctive core surrounded by an outer encapsulant (Singh et al., 
2010, Birnbaum et al., 2003). Nanotechnology is the application of science and 
engineering to fabricate structures of dimensions in the nanometer scale (Nalwa, 2000).  
 
Nanotechnology, first coined by Japanese engineer Norio Taniguchi in 1974, 
originally implied the control of materials on the order of nanometers, more 
specifically in the range of 1 – 100 nm, and has since developed into a science of 
intentional creation, manipulation and characterisation of the macro-molecules 
(Dingman, 2008; Resnik & Tinkle, 2007). The sub-micron dimensions give rise to 
unique shape, orientation, surface chemistry, reactivity and topology, which are 
translated into unusual electrical, optical, magnetic, mechanical, thermal and 
biological properties for these materials (Laurencin & Nair, 2008). However, 
challenges persist at controlling the morphology, structure, composition, and size of 
nanomaterials; factors which define the unique physical properties of the resulting 
materials (Lieber, 2003). Increasing knowledge in biocompatible polymers such as 
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polysaccharides, lipids and biopolyesters has spurred advances in the application of 
micro-nano-technology in functional food and drug delivery systems. 
 
1.1.2 MICRO-NANO-TECHNOLOGY FABRICATION APPROACHES 
The fabrication of micro-nano-materials can be broadly distinguished into two general 
pathways, namely top-down and bottom-up. The top-down approach involves 
reducing large materials or structures using various physical or physicochemical 
methods down to micro- or nano-dimensions. This approach may result in costly 
sample loss in the disposal of excess materials. Meanwhile, the bottom-up approach 
involves building structures up to the desired micro- or nano-dimensions from the 
components’ atomic or molecular phases. While this could be time consuming, the 
bottom-up approach is generally preferred due to greater energy efficiency and better 
control of the structure and properties of nanomaterials formed (Viney, 2004). 
Examples of top-down and bottom-up fabrication methods are grinding or milling, and 
nanoemulsion formation, respectively. There are other fabrications methods in both 
approaches, which are continuously being refined to achieve the desired properties for 
distinct applications in food and drugs.  
 
a) Nanofibers 
Nanofibers are commonly fabricated using methods such as phase separation, self 
assembly, template synthesis, drawing and electrospinning. Phase separation 
technique (Figure 1.2 A) applies polymer dissolution, gelation, and solvent extraction 
to produce porous nanofibrous structure. Dissolved polymers undergo gelation, 
leading to the production of two physically incompatible phases, and subsequently 
phase separation. The gel phase separated from the solvent phase is freeze-dried to 
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obtain porous nanofibrous structure. Mechanical properties of the nanofibers can be 
engineered to suit specific applications by varying the polymer type and concentration 
used (Ramakrishna et al., 2005). Commonly used polymers to fabricate nanofibers 
using the phase separation technique include biodegradable polymers such as poly(L-
lactic) acid (PLLA) and its derivatives (Kuan et al., 2012). 
 
The self-assembly technique (Figure 1.2 B) involves the spontaneous self-arrangement 
of small building molecules under appropriate intermolecular forces, which can be 
achieved by manipulation of the physical and chemical conditions such as pH, 
temperature and solute concentrations. The basic building blocks and the strength of 
the intermolecular forces dictate the morphology of the formed nanofibers (Kuan et 
al., 2012). Biomolecules such as proteins, peptides and DNA have been processed via 
self-assembly to form micro-nano-structures used in tissue cell cultures (Rajagopal & 
Schneider, 2004; Zhang et al., 2004; Doyle, 2006). 
 
Drawing is used to synthesise micro-nano-fibers by drawing out liquid droplet with a 
diameter of a few micrometers using a micropipette (Figure 1.2 C). The drawing 
process is repeated several times on every droplet and pulled fibers are deposited on 
the surface by touching it with the end of a micropipette (Kuan et al., 2012). Although 
tedious, the technique produces long single micro-nano-fibers via a simple process 
requiring minimal equipment. Polystyrene nanofibers for biological scaffoldings were 
produced using this technique in a study by Nain et al. (2006). 
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Figure 1.1 Nanofiber fabrication techniques (A) Phase separation, (B) Self assembly, 
(C) Drawing and (D) Template synthesis (adapted from Figures 1-4, Pp. 56-57, Kuan 
et al., 2012, Nanotech: Propensity in Foods and Bioactives. Crit Rev in Food Sci Nutri 
52: 55-71) 
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Template synthesis (Figure 1.2 D) is extensively used in the production various types 
of nanofibers such as hollow nanofibers, composite nanowires and segmented 
nanowires. The nanofiber diameters are determined by the size of the pores on the 
template (Ramakrishna et al., 2005; Kuan et al., 2012). The fundamentals and various 
technical approaches developed for the template-based synthesis of nanorod, nanowire 
and nanotube arrays was reviewed by Cao & Liu (2008).  
 
b) Micro-nano-particles 
Micro-nano-particles can be fabricated using mechanical and physicochemical 
methods such as grinding, emulsification, solvent evaporation, spray drying and 
coacervation. In mechanical grinding, large structures or polymers are milled down 
using mechanical force to smaller size particles. The morphology and size of the 
micro-nano-particles can be controlled by milling time and the force applied. Thin 
drug-containing ethylcellulose films in cryogenic conditions were milled to form drug 
encapsulated microparticles whereby the particle shape and size where also dictated 
by the thickness of the film (Oliveira & Mano, 2011). 
 
Spray drying is another physical approach which is widely used in the preparation of 
pharmaceuticals and microencapsulation. The method involves dispersing a drug or 
polymer solution into continuous stream of hot air to vaporise drug solutions, 
producing dried micro-nano-particles. The size of the particles is dependent on several 
parameters such as polymer/drug solution loading rate, drying temperature, and 
spraying rate (Elversson & Millqvist-Fureby, 2005; Oliveira & Mano, 2011). However, 
the utilisation of high temperature in this process limits the application to heat-stable 
compounds. 
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Emulsification is one of the most commonly used approaches for micro-nano-particle 
fabrication. The approach is often coupled with other strategies such as solvent 
evaporation and salting out to form particles of desired properties. In emulsification, 
polymers or drugs are dissolved in a solvent, to which another solution which is non-
miscible is added. Pure polymeric micro-nano-particles are usually produced by a 
single oil-in-water (o/w) emulsion (Oliveira & Mano, 2011). Emulsifiers or surfactants 
are often used, together with mechanical force such as vigorous homogenization, to 
facilitate the formation of micro-nano-droplets within the emulsion.  
 
In salting out technique, the addition of water or aqueous solution to the emulsion 
causes the diffusion of organic solvent into the aqueous phase, simultaneously 
aggregating the water insoluble polymer and bioactive compounds to form micro-
nano-particles (Weiss et al., 2006). The phase separation causes the polymer and 
bioactive compounds to precipitate into micro-nano-spheres, which is collected by 
evaporating the volatile solvent under reduced pressure conditions or continuous 
stirring (Weiss et al., 2006). Salting out minimises stress to protein encapsulants and 
does not require high processing temperature, thus it is useful in processing heat 
sensitive substances (Zohri et al., 2009). In solvent evaporation, immiscible volatile 
organic solvent is added to an aqueous solution containing surfactant and 
homogenised to form an emulsion, followed by the evaporation of the solvent to 
collect the resulting micro-nano-particles. This method is has been applied to produce 
micro-nano-particles containing albumin, testosterone and cyclosporine A (Zohri et 
al., 2009). Nanoliposomes have also been fabricated by dissolving in organic solvents 
followed by removal of the solvent via evaporation and hydration in aqueous buffers 
(Wu et al., 2007; Kuan et al., 2012). 
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Despite the ease of micro-nano-particle formation using emulsification techniques, the 
use of solvents in the production of micro-nano-particles may limit its application in 
food and pharmaceuticals. Hence, other methods with better solvent removal 
technique or minimal use of solvents have been proposed and applied, such as 
coacervation, ionic gelation, super critical technology and polymerisation (Ochekpe 
et al., 2009). A new technique supercritical fluid mixing involves spraying a 
polymer/bioactive solution into supercritical fluid which results in the dissolution of 
the solvent in the supercritical phase and precipitation of the micro-nano-particles 
(Oliveira & Mano, 2011). The resulting product is solvent free in the range of 1 – 120 
μm, depending on the properties of polymers used such as molecular weight, crystal 
structure, glass transition temperature, and solubility (Oliveira & Mano, 2011). 
 
Most of these methods have some disadvantages such as low drug-loading efficiency, 
limitations to scale up, particle-size polydispersity, low ability to fabricate small 
particles (below 100 nm), and difficulties for incorporation of hydrophilic drugs 
(Zamani et al., 2013). Moreover, the usage of organic solvents, high shear stress and 
high temperature, may cause the degradation of bioactive compounds which are used 
in the design of delivery systems (Zamani et al., 2013). 
 
1.1.3 ELECTROSPINNING AND ELECTROSPRAYING 
A novel technology which may serve as an alternative to the conventional micro-nano-
structure fabrication methods is the electrohydrodynamic techniques. The technology 
encompasses electrospinning and electrospraying in the production of fibers and 
particles, respectively, often in sub-micron dimensions. 
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The electrohydrodynamic technology utilises electrostatic force to draw out polymeric 
solutions from a fine orifice. Depending on the properties of the solution and operation 
parameters, the drawn solution droplets are spun into fibers or sprayed into particles. 
The subsequent rapid evaporation process results in dry, solvent-free structures which 
have been reduced to nano-size. The quality and characteristics of the final product 
are determined by the elasticity, viscosity, temperature, humidity, conductivity and 
surface tension of the polymer, strength of the electric field, and the distance between 
the orifice and collector (Heunis et al, 2010). Thus, the size and properties of 
nanofibers or micro-nano-particles can be designed to suit specific applications by 
modifying the parameters of the spinning process (voltage, spinning distance, flow 
rate) and that of the spinning solution (viscosity, conductivity, surface tension) (Munir 
et al., 2009; Lopez-Rubio et al., 2009; Rezvanpour et al., 2010).  
 
Electrospinning into nanofibers occurs when polymer solutions of high chain 
entanglements and elasticity are used. The network of entanglements enables the 
solution to remain elastic and elongate during the whipping motion of the electrically-
charged fluid jet. Electrospun nanofibers from synthetic and natural polymers such as 
polyamide, nylon, polyethylene oxide, protein, peptides, and carbohydrates have been 
applied in drug delivery system, tissue engineering and functional material 
development (Ramakrishna et al., 2005; Lu & Ding, 2008; Kuan et al., 2012).  
 
Electrospraying or electrohydrodynamic atomisation applies the same principles of 
electrospinning to produce micro-nano-particles from solutions of high surface tension 
and low chain entanglements. The technique can be used to fabricate particles with 
narrow size distribution, ranging from 200 μm to 2 mm (Oliveira & Mano, 2011). 
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When the solution droplet of low chain entanglements is electrically charged, it 
deforms and disrupts into droplets instead of elongated fibers. The rapid evaporation 
of solvent and further particle fission reduces the size of the droplets into dry 
microparticles upon deposition onto the grounded collector. Electrospraying has the 
advantage of higher loading efficiency, narrow particle-size distribution, and ease of 
particle synthesis due to single-step processing (Zamani et al., 2013). 
 
 
Figure 1.2 Illustrations of electrospinning (adapted from Figure 1. The common setup 
and working principle of electrospinning, page 420, Li et al., 2010, Core-Shell 
Nanofibers: Nano Channel and Capsule by Coaxial Electrospinning. In: Nanofibers, 
Ed: Ashok Kumar) 
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Figure 1.3 Illustrations of electrospraying (adapted from Figure 1. Schematic of the 
electrospray crystallization process, page 1, Ambrus et al., 2013, Analysis of 
submicron-sized niflumic acid crystals prepared by electrospray crystallisation. 
Journal of Pharmaceutical and Biomedical Analysis 76: 1-7) 
 
 
Since electrospraying was first systematically studied by Zeleny (1914) and theoretical 
explained by Taylor (1964), many researchers have investigated the mechanisms that 
induce an electric charge on the surface of a liquid and stretch the meniscus in the 
direction of the electric field (Grafahrend et al., 2010). As such, several modes have 
been observed on the droplets drawn into the electrospining or electrospraying process 
(Figure 1.4). The most stable mode observed is the cone-jet mode, which when 
achieved, results in a stable electrospinning or electrospraying process and 
monodispersed structures. However, with the increasing strength of applied voltage, 
four other operation modes were observed, namely the dripping mode, silver-bullet 
mode, compound cone-jet mode (if possible), and pulsated cone-jet mode (or multi-
jet mode) (Mei & Chen, 2008). The cone jet mode only occurs when the liquid 
meniscus assumes the shape of a sharp cone, obtained by balancing the electrostatic 
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and capillary pressure acting on a conical surface for ideal, static equilibrium 
conditions (Grafahrend et al., 2010). 
 
 
 
Figure 1.4 Characteristic spray-modes found during electrohydrodynamic process 
(adapted from Figure 2. Characteristic spray-modes found during 
electrohydrodynamic atomization of polymer solutions, page 69, Hogan et al., 2007, 
Controlled size polymer particle production via electrohydrodynamic atomization. 
Colloids and Surfaces A: Physicochemical and Engineering Aspects 311(1–3): 67-76). 
 
The resulting micro-nano-particles and nanofibers fabricated using 
electrohydrodynamic processes have been applied in various fields such as textile, 
construction, biotechnology, food, medical and pharmaceutical. While the use of 
micro-nano-particles and nanofibers in the medical field started with drug delivery, 
the application has promptly expanded into tissue engineering, with vast literature on 
various biocompatible synthetic or natural polymers being used. The use of nanofibers 
and micro-nano-particles can be justified for the following pharmaceutical 
applications:  prolonged release dosage forms, enteric-coated dosage forms for 
selective release in the digestive tract, masking the bitter taste drugs, aid in the addition 
of oily medicines to tableted dosage forms, protect drugs from environmental hazards 
such as humidity, light, oxygen or heat, decrease contact with toxic or noxious 
substances, and increase the absorption efficiency of the encapsulated bioactive (Singh 
et al., 2010). 
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1.1.4 MICRO-NANO-TECHNOLOGY IN DELIVERY SYSTEMS 
The development of delivery systems for biologically active compounds is an 
important issue in modern food and pharmaceutical technology. The term 
“microencapsulation” designates a defined technology of wrapping solids, liquids, or 
gases in small capsules, which can release their contents under specific circumstances 
(Lopez-Rubio et al, 2009). Micro-nano-technology is widely applied in food and 
pharmaceutical sciences, especially in the design of delivery systems. Since both 
nano- and micro scale systems have shown critical advantages in developing various 
clinically useful drug delivery systems, thus “nanotechnology” includes 
“microtechnology,” and “nanofabrication” or “nanomanufacturing” and its micro 
counterparts (Park, 2007). In drug delivery systems, applicable dimensions typically 
range from truly nanosystems to microparticles in the range of 100 μm (Park, 2007). 
Meanwhile, nanotechnology generally affects the food industry in the development of 
functional food delivery system, food packaging, food security and molecular 
synthesis of new functional food compounds (Moraru et al., 2003). 
 
Drug delivery emphasises on transport and targeted delivery of drugs to desirable sites, 
while concurrently minimising side effects on other tissues (Tran et al., 2009). 
Controlled delivery systems via micro-nano-particles improve the therapeutic efficacy 
and safety of drugs (Vasita & Katti, 2006). Micro-nano-structures are able to exploit 
biological pathways and provide unprecedented advantage of size by delivering 
proteins, drugs and genetic material to previously inaccessible cellular and 
intracellular targets, leading to greater therapeutic benefits and reduced side effects, 
due to its selective sub-cellular delivery (Faraji & Wipf, 2009). The greater surface 
area of micro-nano-particles also gives rise to enhanced bioactivity compared to their 
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larger-sized counterparts. Nanoparticles are also able to establish sustained-release 
drug profiles and prolong compound residence time in the gastrointestinal tract, thus 
providing efficient delivery of compounds to targeted sites (Chau et al., 2007).  
 
The application of nanofibers in delivery systems and tissue engineering is highly 
feasible due to the remarkable characteristics such as the high surface area-to-volume 
ratio, high interconnected porosity with tunable pore size, possibilities for efficient 
surface functionalization, adjustable surface morphology, and structural similarity to 
the extracellular matrix (Oliveira & Mano, 2011). As for microparticles, the size 
polydispersity is often the constraint limiting the potential application in drug-delivery 
system, especially inhalable drugs where the aerosol particles with homogeneous size 
and suitable aerodynamic diameter (1–5 μm) are essential (Zamani et al., 2013). 
 
(a) Micro-Nano-particles 
Micro-nano-particles present various advantages over conventional drug delivery 
systems, including effective protection of the encapsulated bioactive agent against 
degradation, controlled or sustained release, targeted release, easy administration and 
reduced toxicity or irritancy due to lowered local concentrations of drug (Singh et al., 
2010). Singh et al. (2010) reviewed the role of micro-nano-particles as drug delivery 
devices for increasing efficiency of drug delivery, improving the release profile and 
drug targeting.  
 
Micro-nano-particles deliver drugs, which are chemically bound, adsorbed or 
entrapped, via inhalation, oral or intravenous routes. Polyethylene glycol (PEG)-
coated (PEGylated) nanospheres used in intravenous drug delivery is enhanced with 
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protection against blood components and plasma proteins, preventing its removal from 
the blood and prolonging systemic circulation (Jagur-Grodzinski, 1999). PEGylation, 
a standard strategy in in-vivo drug targeting, provides stealthing of nanoparticles, or 
invisibility to macrophages and phagocytes, hence prolonging its systemic half-life. 
Nanoparticles are also suitable for intravenous delivery as they are small enough to 
safely pass through the body’s smallest vessels, and have increased surfaced area for 
rapid dissolution (Cohen-Sela et al., 2007).   
 
One of the largest applications for drug delivery is in cancer treatment where a proper 
amount of drugs needs to be directed to the targeted tissue while minimising unwanted 
effects on normal, healthy tissue (Tran et al., 2009). Biodegradable self-assembled 
nanoparticles are engineered for targeted delivery of anticancer drugs, serving as a 
vehicle to ferry large doses of chemotherapeutic agents into malignant cells while 
sparing healthy cells (Sinha et al., 2006). Size-specific anticancer drug nanostructures 
are able to penetrate tumor microvasculatures via pores ranging from 100 – 1000nm, 
but are kept out of healthy tissues such as the heart, brain and lung by tight intercellular 
junctions measuring less than 10nm (Hughes, 2005).  
 
Bisht et al. (2008) synthesised and studied the drug delivery efficacy of amphiphilic 
nanoparticles comprising of N-isopropylacrylamide, methylmethacrylate, and acrylic 
acid. The nanoparticles readily encapsulate water insoluble drugs such as rapamycin 
for cancer therapy and showed favourable in-vivo pharmacokinetics of the drug, with 
no apparent systemic toxicities from oral administration in mice (Bisht et al., 2008). 
Anticancer drugs such as paclitaxel and tamoxifen have been encapsulated in 
poly(lactic-co-glycolic) acid and polycaprolactone nanoparticles with high 
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encapsulation efficiency (90 – 100 %), and respectively demonstrated enhanced anti-
tumoral efficacy and increased accumulation in tumour with extended systemic 
presence compared to free drug (Kumari et al., 2009). 
 
Peptide drugs and proteins previously faced limitations in oral delivery due to 
epithelial barriers and susceptibility to enzymatic degradation in the gastrointestinal 
tract. They are now encapsulated in nanocarriers, which serve as protective vehicles, 
enhancing the oral bioavailability of peptides such as insulin and salmon calcitonin 
(Ochekpe et al., 2009). Insulin has been encapsulated in biopolymeric nanoparticles 
such as poly(lactic-co-glycolic) acid, polycaprolactone and chitosan, all of which 
showed high encapsulation efficiency (75 – 96 %), preserved biological activity and 
enhanced intestinal absorption (Kumari et al., 2009). Damgé et al. (1997) 
demonstrated the protective effect of poly-(alkyl cyanoacrylate) nanocapsules in oral 
administration of insulin in a rat study. Insulin-loaded nanospheres with mean size of 
145nm were dispersed in oily medium containing surfactants and administered 
perorally in streptozotocin-induced diabetic rats. The authors observed a 50% decrease 
of fasted glycemia from the second hour up to 10-13 days, indicating the sustained 
release and bioactivity of the nano-encapsulated insulin (Damgé et al., 1997). Elsayed 
et al. (2009) recently assessed the storage stability of insulin-loaded chitosan 
nanoparticle preparation using streptozotocin-diabetic rats as in-vivo models. The 
authors found insignificant difference in pharmacological activity between the groups 
taking fresh preparation and stored preparation, indicating the storage biological 
stability of the nano-encapsulated insulin (Elsayed et al., 2009). 
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In tissue engineering and regenerative medicine, microparticles with diameters 
ranging from 1 to 10 μm, are incorporated into porous scaffolds to deliver encapsulated 
bioactive agents to incorporate osteoconductive materials in the system (Oliveira & 
Mano, 2011). Other biologically active agents which have been encapsulated into 
microparticles include hormones such as calcitonin (Woo et al., 2008). 
 
(b) Liposomes 
Stealth liposomes are being studied as carriers for hydrophilic anticancer drugs such 
as doxorubicin and mitoxantrone (Samad et al., 2007). In addition to extended 
systemic circulation time and reduced toxicity, liposomes increase efficacy of cancer 
therapy by facilitating preferential localisation of anti-cancer drugs in tumors via 
increased endothelial permeability and reduced lymphatic drainage, leading to 
enhanced permeability and retention effect (Wu et al., 2007). Anti-cancer drug 
doxorubicin was encapsulated in pH-sensitive micelles with acid-labile acetal groups 
on the core-forming dendrimer periphery, designed for targeted release in acidic 
environment (Cui et al., 2008).  
 
Liposomes are modified to be degraded in low pH or fuse with the endosomal or 
lysosomal membranes (Cohen-Sela et al., 2007). Such modifications allow for 
selective release of encapsulated compounds, by modulating the chemical properties 
of nanoparticles to suit the environment in which it is to resist or rupture. Surface 
modification by attaching polyethylene glycol units extends systemic circulation of 
liposomes, while conjugation to ligands adapts liposomes to targeted delivery and 
confers stability (Ochekpe et al., 2009). Liposomes are also being developed to cross 
the blood brain barrier, which has challenged central nervous system drug delivery 
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with its relatively impermeable endothelial cells consisting of tight junctions and 
specific receptor-mediated transport systems (Mohanraj & Chen, 2006).   
 
(c) Carbon Nanotubes 
Carbon nanotubes (CNTs) are excellent sub-cellular delivery vehicles which are 
functionalised with bioactive peptides, proteins, nucleic acids and drugs (Bianco et al., 
2005). CNTs comprise of single-walled nanotubes (SWCNT) and multi-walled 
nanotubes (MWCNTs). CNTs drug delivery system is highly promising due its 
physicochemical and structural properties which provide advantages in terms of safety 
and monitoring means. CNTs have among the safest chemical composition of purely 
carbon; unique one-dimensional structure and tunable length ideal for investigating 
size and shape effects in-vivo; and intrinsic spectroscopic properties i.e. Raman and 
photoluminescence which provide valuable means for monitoring in-vivo behavior 
and drug delivery efficacy (Liu et al., 2008). As such, CNTs have become highly 
relevant in oncology and imaging applications.   
 
CNT have been studied as a template for presenting bioactive peptides to the immune 
system (Bianco et al., 2005). Drugs are internalised into the cells at the targeted sites 
either with or without the carriers. CNTs are internalised via endocytosis or 
endocytosis-independent pathways i.e. via insertion and diffusion through the lipid 
bilayers of cells (Tran et al., 2009). Nanotubes functionalised with antibiotics such as 
amphotericin B have been reported to be easily internalised into mammalian cells 
without toxic effects and preserved high antifungal activity against pathogens (Bianco 
et al., 2005).  
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CNTs plays a big role in the progress of cancer treatment, providing powerful targeting 
ability and potential for large cytotoxic payload, hence dramatically enhancing the 
efficacy of conventional pharmaceuticals (Cohen-Sela et al., 2007). The overall 
efficacy has been found to be enhanced by the intrinsic spectroscopic property of 
CNTs in the near IR (NIR) region which effectively destroyed cancer cells in-vitro 
and efficient drug-loading attributable to its high surface area (Liu et al., 2008). The 
size of CNTs can be modified to specifically penetrate the pores of blood vessels in 
tumor tissues which, at 100 – 700 nm are distinctively larger than the pores of blood 
vessels in healthy tissues at 2 – 6 nm (Tran et al., 2009).   
 
One of the pioneering reports of in-vivo efficacy of CNTs as drug delivery vehicles 
for tumour treatment in mice was reported by Liu et al (2008). The authors studied the 
SWCNT delivery of paclitaxel, a common cancer chemotherapy drug. The 
PolyEthyleneGlycolated (PEGylated) SWCNTs functionalised with paclitaxel 
displayed strong therapeutic efficacy via tumour suppression achieved at low injected 
drug dose, suggesting the potential of CNTs in future cancer therapeutics. In another 
study, the strong absorption of SWCNT in the NIR region was used to selectively heat 
up cancer cells in-vivo. SWCNTs are functionalised to selectively bind to receptors 
which are over-expressed in cancer cells, thus allowing selective heat treatment on 
cancer cells, sparing the surrounding normal cells (Wong et al., 2005). This 
hyperthermia treatment of cancer uses controlled, elevated heat to kill cancer cells, 
which are more susceptible to heat compared to normal cells, due to impaired heat 
dissipation system (Tran et al., 2009). 
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(d) Nanofibers 
Nanofibers produced via electrospinning forms porous network with very large 
surface area-to-volume ratio, thus rendering nanofibers suitable agents for controlled 
drug release and as scaffolds for tissue engineering. Electrospun nanofibers have been 
explored as potential biomedical device and delivery carriers for bioactive agents such 
as antibiotics, anti-tumor agents, proteins and plasmid DNA (Xu et al., 2006; Kim et 
al., 2007; Cui et al., 2008).  
 
Polysaccharides such as chitosan with intrinsic bacteriostatic activity in addition to 
advantageous biological properties such as hemostatic activity, biodegradability and 
non-toxicity, have potential to be developed into revolutionary nanofiber wound-care 
applications which expedites healing while minimising infection risks (Yacoby & 
Benhar, 2008). The hollow morphology of nanofibers contributes potential 
encapsulating and sustained release properties (Burke & Luzhansky, 2007). Xu et al. 
(2006) reported that 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU)-loaded 
poly(ethylene glycol)–poly(l-lactic acid) (PEG–PLLA) diblock copolymer fibers 
would exhibit anti-tumour activity over 72 hours while pristine BCNU lost the activity 
after 48 hours (Xu et al., 2006). The embedding of the anti-cancer drug within polymer 
fibers preserved the bioactivity of the drug and the amount of drug loaded were 
modified to control drug release (Xu et al., 2006; Sill & von Recum, 2008).  
 
Additionally, electrospun nanofibrous have been found to be able to provide controlled 
delivery of hydrophilic and hydrophobic drugs, of which their release can be tailored 
by modulation of nanofibrous scaffold’s morphology, porosity, and composition 
(Vasita & Katti, 2006). Immediate release nanofibers are created by water-soluble 
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polymers, enteric-release nanofibers by enteric polymers such as methacrylic acid 
copolymers and sustained-release nanofibers by polylactic acid or polyacetate 
polymers (Burke & Luzhansky, 2007). Verreck et al. (2003) studied the delivery of 
hydrophobic drugs intraconazole and ketanserin incorporated as amorphous 
nanodispersion on polyurethane nanofibrous scaffolds. Nanofibers have also been 
electrospun from water-soluble polymers such as polyvinyl alcohol, whereby the 
fiber/film-forming ability and easy cross-linking was useful in developing wound 
treatment (Yacoby & Benhar, 2008). Electrospun poly(vinyl alcohol) nanofibers, with 
inherent non-toxicity and good biocompatibility, were studied for controlled delivery 
of ketoprofen, a non-steroidal anti-inflammatory drug (NSAID) (Kenawy et al., 2007). 
The cross-linked poly(vinyl alcohol) nanofibers released 20.04 % of its drug content 
within two hours and a total of 69.18 % of its drug content within two weeks.  
 
In addition to drugs, nanofibers have also been formulated to encapsulated biological 
material such as DNA, proteins, enzymes and other small molecules (Salalha et al., 
2006). Plasmid DNA and bacteria were found to be released intact and viable from 
electrospun nanofibers, suggesting the potential of nanofibers for applications in gene 
therapy (Salalha et al., 2006). 
 
Nanolaminates thin films of nanofibers formed by multiple nanolayers of 
carbohydrates, proteins, charged lipids or colloidal particles (Weiss, Takhistov & 
McClements, 2006).  Nanolaminates containing bioactives agents such as anti-
browning agents, enzymes, colours, flavours, antioxidants and nutrients are coated on 
the charged surface of the product to be laminated (Decher & Schlenoff, 2003). It is 
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mainly applied in food packaging as edible coating that prevents moisture, lipids and 
gas diffusion in meats, fruits, vegetables and confectionery (Kuan et al., 2012). 
 
1.2   AGROWASTE AND PROBIOTICS AS MODELS FOR 
ELECTROSPINNING FUNCTIONAL NANOFIBERS  
1.2.1  INTRODUCTION  
Agrowastes are wastes generated from agricultural and agro-based activities, which 
are carried out on more than 6 million hectares of land in Malaysia. The abundance 
and low cost of agrowaste has promoted much research in converting the waste into 
functional products and reduce waste disposal issues in agriculture industry. With their 
unique nutrient composition and physicochemical make-up, agrowastes have the 
potential to be recycled into profit-generating products such as organic fertilizers, 
fermentation medium and bio-fibers with extensive application in the construction, 
textile, paper and even food industries. Prakongpan et al. (2002) incorporated dietary 
fiber and cellulose from pineapple core into beef burgers to increase the weight after 
cooking and pineapple core fiber was found to improve the texture of the product. The 
function of agrowaste as dietary fibers may even be extended to serve as prebiotics, or 
substrate for beneficial bacteria called probiotics which promote gastrointestinal 
health. 
 
Probiotics are "live microorganisms which, when administered in adequate amounts, 
confer a health benefit on the host", according to the World Health Organization. 
Probiotics confer health benefits by promoting the proliferation of beneficial 
microflora in the gastrointestinal microenvironment (Lye et al. 2009). One of the most 
common probiotic strains are of the genus Lactobacillus.  Species of lactobacilli that 
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have been isolated from the human gastrointestinal tract include the L. acidophilus, L. 
fermentum, L. plantarunm, L. brevis, L. casei and L. leichmanii. L. acidophilus is able 
to survive in low pH environments of pH 4 and below, as well as the harsh conditions 
of the gastrointestinal tract en route to the small intestines where it proliferates. L. 
acidophilus is a facultative anaerobe which produces only lactic acid as the sole 
metabolite at optimum growth temperature of 37 to 42˚C. The bacterium is physically 
characterised as a rod-shaped of 2 to 10 µm. The health promoting effects of probiotics 
are well established and probiotics have been increasingly used as functional adjuncts 
such as soymilk, fruit juices, meat derivatives, cereal-based foods in addition to 
conventional probiotic supplements, such as cultured milk and freeze-dried powder 
capsules. The therapeutic dose of probiotics via oral administration is in excess of 109 
colony forming units (cfu)/day. 
 
1.2.2  AGROWASTE FROM OIL PALM AND SOY (OKARA) AS 
FUNCTIONAL FIBER SOURCE 
Indonesia and Malaysia are the largest oil palm producers, while the U.S.A. and Brazil 
are the largest producers of soybean crop. These agriculture industries are major 
contributors to biomass waste. Approximately two hundred billion tonnes of 
lignocellulosic wastes being produced annually, creating environmental concerns 
(Mohanty et al., 2000). These wastes are rich in fibers and nutrients, making them 
potentially valuable using proper recycling technologies. Only 10% of the oil palm 
crop is economically valuable, used for the production of palm oil, while the remaining 
90% constitutes of oil palm trunks (OPT), oil palm fronds (OPF), empty fruit bunches 
(EFB) and palm pressed fibers (PPF) which are disposed as agriculture waste or are 
recycled to other industries (Ratnasingam et al., 2008). Oil palm trunk (OPT) contains 
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30% lignocelluloses which are constituted of cellulose, hemicelluloses and lignin 
(Ratnasingam et al., 2008). Oil palm frond (OPF) contains high levels of holocellulose 
(82.2 %) and α-cellulose (47.6%), as well as lignin (15.2%) (Wan Rosli et al., 2007). 
Okara, the main solid waste from soy and tofu processing industry, is constituted of 
up to 49 % fiber (Prestamo et al., 2007). Conventionally, most oil palm and soy 
biomass are being converted to biofuel substrate and animal feed. With further 
research and development, the exploitation potential of these agriculture waste 
remains expandable as the material is locally abundant, renewable and relatively 
economical. 
 
Oil palm and soy agrowastes are good sources of fiber which includes cellulose, 
hemicelluloses, lignin, pectin, gums and other polysaccharides. Soluble and insoluble 
dietary fiber have been found to confer a wide range of health benefits, including 
general reduction in risk of civilisation diseases such as cardiovascular diseases, 
gastrointestinal diseases and obesity. Dietary fiber is also noted as prebiotics which 
are substrates for the growth and proliferation of beneficial gut bacteria, hence 
enhancing the beneficial properties of probiotics. Thus, the market demand for 
palatable high-fiber products as functional foods with a low glycemic index and 
hypocholesterolemic properties is increasing. However, high-fiber content in food is 
often associated with undesirable sensory properties due to the inherent properties of 
fibers being coarse and grainy. The food industry has developed compound coatings 
which can effectively mask fibrous mouth feel associated with dietary fiber. However, 
compound coatings are essentially made up of fats and carbohydrates, which increase 
the caloric value of the food. The diminutisation of fibers to nano-size can reduce the 
undesirable organoleptic properties and eliminate the need for additional processing 
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or high calorie additives which will negate the beneficial properties of the fibers. Apart 
from supplementing dietary fiber, the oil palm and soy agrowaste are also processed 
to form composites in textile and construction materials. 
 
1.2.3  FUNCTIONAL PROPERTIES OF PROBIOTICS  
The physiological benefits of consuming probiotics are well documented, with the 
most evidence and extensive use in the maintenance of gastrointestinal health. Past 
studies have shown the therapeutic activities of various strains probiotics in 
gastrointestinal disturbance such as diarrhea, irritable bowel syndrome, rotavirus, 
Helicobacter pylori and Clostridium difficile infections of the gut (Guandalini et al., 
2000; Cats et al., 2003; Whorwell et al., 2006; McFarland, 2009; Moayyedi et al., 
2010).  
 
A comprehensive meta-analysis conducted by McFarland (2006) revealed that 
probiotics resulted in significant prevention of antibiotic-associated diarrhea and C. 
difficile infections compared to placebo groups, in 25 randomised controlled trials 
involving 2810 subjects. Similarly, a systematic review by Moayyedi et al. (2010) 
revealed significant alleviation of irritable bowel syndrome symptoms such as pain 
and flatulence compared to the placebo groups in all 19 randomised controlled trials 
involving 1650 patients. L. acidophilus and L. casei Shirota showed antagonistic 
action against Helicobacter pylori (Cats et al., 2003) while L. rhamnosus GG and B. 
lactis BB-12 were effective for prevention and treatment of acute diarrhoea caused by 
rotaviruses in children (Guandalini et al., 2000).  The mechanisms of action by 
probiotics in exerting these effects include competitive exclusion of pathogenic 
bacteria for nutrients and adhesion sites (Rolfe, 2000), production of antimicrobial 
